HIV Reservoir Characterisation Symposium

HIV stably integrated within the host cell genome is considered the final hurdle to cure one of the most important infectious diseases mankind has ever faced. Latent HIV reservoir is able to refuel infection once the treatment is stopped and therefore a better understanding of both, the composition and the size of this reservoir will be important to aid the development of cure strategies as well as to monitor the efficacy of therapeutic interventions to reduce the HIV reservoir. The HIV Cure and Reservoir Symposium will comprehensively summarize the state of the art in HIV cure strategies and diagnostic tools to monitor therapeutic interventions. The Symposium will take place in the picturesque city of Ghent, Belgium where an international expert panel will guide you through the newest developments in the HIV cure field, focusing on reservoir characterization and novel clinical strategies to achieve HIV cure.



Target audience

The symposium aims to attract a broad public of basic and translational researchers with an interest in HIV research or in other persistent infectious diseases.



Expected number of participants

150-200



Tentative program

Monday 16.09.2019

 SpeakerSubject
13:10-13:30Linos VandekerckhoveIntroduction: Tools to evaluate the HIV-1 reservoir
TREATMENT INTERRUPTION STUDIES:
in search of a biomarker for PTC
13:30-14:00Eric Florence Treatment interruption in patients with a low reservoir: ISALA study
14:00-14:30John FraterBiomarkers in treatment interruption studies
14:30-14:502 selected abstracts2x10 min bullet presentation
14:50-15:20Coffee Break
UNMASKING THE VIRAL RESERVOIR : Themed discussion
15:20-16:20Maria Buzon, Marion Pardon, Susan Pereira RibeiroUnmasking the viral reservoir for downstream analysis
16:20-16:402 selected abstracts2x10 min bullet presentation
16:40-17:00Round table and discussion
17:00-17:20Coffee Break
17:20-17:30
Linos VandekerckhoveAnnouncement inaugural lecture
17:30-18:10Guido VanhamA lifetime search for eliminating HIV
18:10Network Reception

Tuesday 17.09.2019

 SpeakerSubject
THE ORIGIN OF PLASMA VIRUS
09:00-9:30Lisa FrenkelIdentifying the source of low level viremia
09.30-10.00Marie-Angélique De ScheerderIdentifying the source of plasma virus during analytical treatment interruption
10:00-10:202 selected abstracts2x10 min bullet presentation
10:20-10:50Coffee Break
THE LAST HURDLE TOWARDS CURE
10:50-11:20Meritxell GenescàResident memory T cells as source of viral reservoir
11:20-11:50Annemarie WensingResults of the ICISTEM cohort
11:50-12:102 selected abstracts2x10 min bullet presentation
12:10-13:30Lunch
BLOCK AND LOCK VS SHOCK AND KILL
13:30-14:10Zeger Debyser & Carine Van LintBlock and lock vs Shock and kill
14:10-14:302 selected abstracts2x10 min bullet presentation
14:30-14:50Round table and discussion
14:50-15:30Coffee Break
15:30-16:00Philipp AdamsPhenotypically characterization of elite and viremic controllers
16:00-16:30To be confirmedTherapeutic vaccination to achieve a functional cure.
16:30-16:502 selected abstracts2x10 min bullet presentation
16:50-17:00Linos VandekerckhoveClosing Remarks


Practical Information

Registration

Click here for more information

Venue

The symposium will take place in Auditorium Oehoe (E1.002) – Block E, Coupure Links 653, 9000 Ghent



Abstract submission

Abstract submission will open from the 20th of March until 15th of June.

Abstract content and editing are the responsibility of submitting author. Organizers will review abstracts and selections will be made based on quality of content. Dissemination of the results will be made on June 30th. 4 abstracts will be selected for a short oral presentation at the symposium and those will be awarded with complimentary registration and accommodation. All abstracts are assigned a poster number for poster presentation during a poster session during the meeting.

Abstract Format

• 2200 characters count including spaces. Also includes title, authors and affiliations.
• No email addresses, phone numbers, hyperlinks, keyword lists, comments, text or image boxes.
• Paragraph breaks between Title, Author & Institute, and abstract body.
• Arial, 11 point, black font.
• For Greek and Scientific symbols, use the Symbol option under the Insert tab in Microsoft Word (or equivalent option in other applications).
• Single spacing, one-inch margins, left justified.
• One abstract per submitting author per meeting. Submitting author and account name must match. Submitting author must be underlined.

Disclaimer

Submission of the abstract signifies consent to publication of the abstract in the Journal of Virus Eradication.

Abstract submission

To submit your abstract, please send an email to karen.vervisch@uzgent.be



Workshop
symposium
Registration